A Novel Therapeutic Approach for Preventing and Treating Atherosclerosis
The proposed technology relates to prevention and treatment of atherosclerosis using inhibiting or reducing the level of carbamylation of various circulating proteins. The technology suggests a method of determining whether an individual is at risk for atherosclerosis, by measuring the level of carbamylated LDL in the individual sample. It suggests a method of assessing the effectiveness of a treatment for atherosclerosis by monitoring carbamylated LDL and/or antibody to carbamylated LDL in said sample. It further provides a method of reducing carbamylation by treating treating said individual with enzymatic or non-enzymatic inhibitors of carbamylation.
Sector: Health care technology
Country: India
Area of Application: Medical industry
Keywords: treating Atherosclerosis, LDL
Advantages: A new therapeutic approach to reduce or prevent carbamylation mediated injury Prevents and treats atherosclerosis.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054
Contact Technology Provider
Technology offer
Interested in this technology?
Request further information or explore potential cooperation with the technology provider.
Technology request
Can you help meet this technology need?
Share a relevant technology, expertise or partnership opportunity with APCTT.